Aerie Pharmaceuticals Company Profile (NASDAQ:AERI)

About Aerie Pharmaceuticals

Aerie Pharmaceuticals logoAerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's primary product candidates are Rhopressa and Roclatan. Its product candidates are designed to lower intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Rhopressa is a once-daily eye drop and a triple-action netarsudil ophthalmic solution. The active ingredient in Rhopressa acts through the inhibition of both Rho Kinase (ROCK) and norepinephrine transporter (NET). Roclatan is a once-daily, quadruple-action product candidate and is a fixed-dose combination of Rhopressa and latanoprost, which is a prescribed drug for the treatment of patients with glaucoma. The Company is engaged in conducting Phase III clinical trials for Rhopressa and Roclatan.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AERI
  • CUSIP:
Key Metrics:
  • Previous Close: $18.92
  • 50 Day Moving Average: $18.14
  • 200 Day Moving Average: $16.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.83
  • P/E Growth: 0.00
  • Market Cap: $523.53M
  • Outstanding Shares: 27,892,000
  • Beta: 1.24
Additional Links:
Companies Related to Aerie Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Aerie Pharmaceuticals (NASDAQ:AERI) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $45.71 (143.55% upside)

Analysts' Ratings History for Aerie Pharmaceuticals (NASDAQ:AERI)
Show:
DateFirmActionRatingPrice TargetDetails
8/23/2016Needham & Company LLCReiterated RatingBuy$45.00View Rating Details
6/2/2016Cantor FitzgeraldInitiated CoverageBuy$44.00View Rating Details
5/16/2016Brean CapitalReiterated RatingBuyView Rating Details
5/3/2016Canaccord GenuityReiterated RatingBuyView Rating Details
3/5/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
9/17/2015JMP SecuritiesBoost Price TargetOutperform$39.00 -> $49.00View Rating Details
9/17/2015Stifel NicolausBoost Price TargetBuy$30.00 -> $40.00View Rating Details
6/5/2015Piper Jaffray Cos.Reiterated RatingBuy$7.00 -> $9.00View Rating Details
3/24/2015MLV & Co.Reiterated RatingBuy$40.00View Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Aerie Pharmaceuticals (NASDAQ:AERI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/3/2016Q216($0.74)($0.72)ViewN/AView Earnings Details
5/2/2016Q116($0.64)($0.72)ViewN/AView Earnings Details
3/1/2016Q415($0.72)($0.64)ViewN/AView Earnings Details
11/3/2015Q315($0.66)($0.56)ViewN/AView Earnings Details
8/5/2015Q215($0.70)($0.59)ViewN/AView Earnings Details
5/7/2015($0.62)($0.70)ViewListenView Earnings Details
3/2/2015Q414($0.46)($0.58)ViewN/AView Earnings Details
11/11/2014($0.40)($0.54)ViewN/AView Earnings Details
8/6/2014($0.34)($0.49)ViewN/AView Earnings Details
5/12/2014($0.35)($0.28)ViewN/AView Earnings Details
3/18/2014Q413($0.25)($0.62)ViewN/AView Earnings Details
12/4/2013Q313($0.25)($10.81)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aerie Pharmaceuticals (NASDAQ:AERI)
Current Year EPS Consensus Estimate: $-2.74 EPS
Next Year EPS Consensus Estimate: $-2.75 EPS

Dividends

Dividend History for Aerie Pharmaceuticals (NASDAQ:AERI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aerie Pharmaceuticals (NASDAQ:AERI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/22/2016Foresite Capital Fund Ii, L.P.Major ShareholderBuy250,000$17.50$4,375,000.00View SEC Filing  
4/15/2015Anand MehraDirectorSell425,000$33.64$14,297,000.00View SEC Filing  
1/8/2015Lifesciences Ii L.P. ClarusMajor ShareholderSell175,000$31.11$5,444,250.00View SEC Filing  
1/5/2015Lifesciences Ii L.P. ClarusMajor ShareholderSell23,620$30.86$728,913.20View SEC Filing  
12/29/2014Lifesciences Ii L.P. ClarusMajor ShareholderSell80,724$30.05$2,425,756.20View SEC Filing  
12/23/2014Lifesciences Ii L.P. ClarusMajor ShareholderSell49,704$30.36$1,509,013.44View SEC Filing  
12/22/2014Lifesciences Ii L.P. ClarusMajor ShareholderSell49,441$30.36$1,501,028.76View SEC Filing  
11/25/2014Anand MehraDirectorSell800,000$26.00$20,800,000.00View SEC Filing  
11/25/2014Group Holdings (Sbs) Advis TpgInsiderSell1,300,000$25.97$33,761,000.00View SEC Filing  
7/10/2014Group Holdings (Sbs) Advis TpgMajor ShareholderSell1,000,000$25.17$25,170,000.00View SEC Filing  
7/9/2014Group Holdings (Sbs) Advis TpgMajor ShareholderSell500,000$25.05$12,525,000.00View SEC Filing  
5/22/2014Anand MehraDirectorSell323,932$16.00$5,182,912.00View SEC Filing  
5/22/2014Iv L.P. AcpMajor ShareholderSell300,000$16.00$4,800,000.00View SEC Filing  
5/16/2014Gerald CagleDirectorBuy1,854$15.07$27,939.78View SEC Filing  
10/30/2013Brian LevyInsiderBuy6,000$10.00$60,000.00View SEC Filing  
10/30/2013Iv L.P. AcpMajor ShareholderBuy110,000$10.00$1,100,000.00View SEC Filing  
10/30/2013Richard J RubinoCFOBuy10,000$10.00$100,000.00View SEC Filing  
10/30/2013Thomas A MitroCOOBuy5,000$10.00$50,000.00View SEC Filing  
10/30/2013Vicente Anido JrCEOBuy28,000$10.00$280,000.00View SEC Filing  
10/25/2013Anand MehraDirectorBuy285,000$10.00$2,850,000.00View SEC Filing  
10/25/2013Lifesciences Ii L.P. ClarusMajor ShareholderBuy321,000$10.00$3,210,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aerie Pharmaceuticals (NASDAQ:AERI)
DateHeadline
nasdaq.com logoNotable Wednesday Option Activity: WMT, AERI, OPHT (NASDAQ:AERI)
www.nasdaq.com - August 24 at 3:21 PM
News IconNeedham & Company LLC Reiterates Buy at Aerie Pharmaceuticals ... - BNB Daily (blog) (NASDAQ:AERI)
www.baseball-news-blog.com - August 24 at 11:37 AM
investornewswire.com logoWill Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Hit $50 Price Target? - Investor Newswire (NASDAQ:AERI)
www.investornewswire.com - August 20 at 8:01 AM
News Icon2016 Pharma CI Conference & Exhibition Welcomes Industry-Leading Experts (NASDAQ:AERI)
www.pharmiweb.com - August 17 at 3:22 PM
finance.yahoo.com logoAERIE PHARMACEUTICALS INC Financials (NASDAQ:AERI)
finance.yahoo.com - August 11 at 3:21 PM
tradecalls.org logoCranbrook Wealth Management Lowers stake in Aerie Pharmaceuticals Inc (AERI) - Trade Calls (NASDAQ:AERI)
www.tradecalls.org - August 9 at 12:05 PM
marketexclusive.com logoAerie Pharmaceuticals Inc (NASDAQ:AERI) Is Finally Set For The Rhopressa NDA - Market Exclusive (NASDAQ:AERI)
marketexclusive.com - August 5 at 8:45 PM
finance.yahoo.com logoAerie Pharmaceuticals Inc. is finally set for the Rhopressa NDA (NASDAQ:AERI)
finance.yahoo.com - August 4 at 9:03 PM
finance.yahoo.com logoAerie Pharmaceuticals Reports Second Quarter 2016 Financial ... - Yahoo Finance (NASDAQ:AERI)
finance.yahoo.com - August 4 at 3:21 PM
tmcnet.com logoAerie Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:AERI)
www.tmcnet.com - August 4 at 11:52 AM
reuters.com logoBRIEF-Aerie pharmaceuticals reports Q2 2016 financial results and provides business update (NASDAQ:AERI)
www.reuters.com - August 4 at 11:52 AM
marketexclusive.com logoAerie Pharmaceuticals Inc (NASDAQ:AERI) Is Finally Set For The Rhopressa NDA (NASDAQ:AERI)
marketexclusive.com - August 4 at 11:51 AM
finance.yahoo.com logoAerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference (NASDAQ:AERI)
finance.yahoo.com - August 4 at 11:51 AM
finance.yahoo.com logoAerie (AERI) Q2 Loss Wider than Expected, Pipeline in Focus (NASDAQ:AERI)
finance.yahoo.com - August 4 at 11:51 AM
biz.yahoo.com logoAERIE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:AERI)
biz.yahoo.com - August 4 at 11:51 AM
businesswire.com logoAerie Pharmaceuticals Reports Second Quarter 2016 Financial ... - Business Wire (press release) (NASDAQ:AERI)
www.businesswire.com - August 3 at 8:58 PM
reuters.com logoBRIEF-Aerie pharmaceuticals reports Q2 2016 financial results and provides business update - Reuters (NASDAQ:AERI)
www.reuters.com - August 3 at 8:58 PM
sg.finance.yahoo.com logoAerie reports 2Q loss (NASDAQ:AERI)
sg.finance.yahoo.com - August 3 at 8:58 PM
nasdaq.com logoAerie owner buys 250,000 shares (NASDAQ:AERI)
www.nasdaq.com - August 3 at 11:53 AM
biz.yahoo.com logoQ2 2016 Aerie Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:AERI)
biz.yahoo.com - August 3 at 11:53 AM
finance.yahoo.com logoDrug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More (NASDAQ:AERI)
finance.yahoo.com - August 2 at 3:19 PM
finance.yahoo.com logoWhat Awaits Aerie Pharmaceuticals (AERI) in Q2 Earnings? (NASDAQ:AERI)
finance.yahoo.com - August 2 at 8:04 AM
finance.yahoo.com logoAerie Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Wednesday, August 3, 2016 (NASDAQ:AERI)
finance.yahoo.com - July 27 at 7:30 AM
fortune.com logoAerie Pharmaceuticals, Inc. (NASDAQ:AERI) Stock Rises, Analysts ... - Review Fortune (NASDAQ:AERI)
reviewfortune.com - July 25 at 3:26 PM
News IconHC Trending Hot Stocks: Aerie Pharmaceuticals Inc (NASDAQ:AERI) Vertex Pharmaceuticals Incorporated (NASDAQ ... - share market updates (press release) (NASDAQ:AERI)
sharemarketupdates.com - July 25 at 8:06 AM
News IconEquity Roundup: Stock Performance Focus on Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Press Telegraph (NASDAQ:AERI)
presstelegraph.com - July 23 at 8:32 AM
investornewswire.com logoIs $50 Price Target Attainable For Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)? - Investor Newswire (NASDAQ:AERI)
www.investornewswire.com - July 23 at 8:32 AM
news.cmlviz.com logoAerie Pharmaceuticals Inc (NASDAQ:AERI) Stock Technicals Hit Strength - CML News (NASDAQ:AERI)
news.cmlviz.com - July 21 at 3:20 PM
fiscalstandard.com logoBroker Outlook For Aerie Pharmaceuticals, Inc. (AERI) - Fiscal Standard (NASDAQ:AERI)
www.fiscalstandard.com - July 21 at 3:20 PM
News IconAerie Pharmaceuticals, Inc. (NASDAQ:AERI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 20 at 3:55 PM
News IconStock Moving Lower for the Month; Investor Update on Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 20 at 11:28 AM
News IconHow Analysts Rated Aerie Pharmaceuticals Inc (NASDAQ:AERI) Last Week? - Consumer Eagle (NASDAQ:AERI)
www.consumereagle.com - July 20 at 11:28 AM
News IconAerie Pharmaceuticals, Inc. (NASDAQ:AERI) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:AERI)
telanaganapress.com - July 18 at 3:20 PM
News IconStock in Positive Territory for the Quarter: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 18 at 8:10 AM
News IconShares Moving Down on the Week: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 17 at 8:05 AM
News IconShares Experiencing a Downtrend: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - TGP (NASDAQ:AERI)
telanaganapress.com - July 16 at 11:44 AM
investornewswire.com logoStrong Sell Calls For Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) At 0 - Investor Newswire (NASDAQ:AERI)
www.investornewswire.com - July 15 at 7:36 PM
News IconAerie Pharmaceuticals, Inc. (NASDAQ:AERI) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 14 at 12:11 PM
news.cmlviz.com logoAerie Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:AERI)
news.cmlviz.com - July 14 at 12:11 PM
News IconShares Losing Ground for the Month; Investor Alert on Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 13 at 11:24 AM
biz.yahoo.com logoAERIE PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:AERI)
biz.yahoo.com - July 13 at 6:31 AM
News IconHow Many Aerie Pharmaceuticals Inc (NASDAQ:AERI)'s Analysts Are Bearish? - Consumer Eagle (NASDAQ:AERI)
www.consumereagle.com - July 12 at 3:22 PM
News IconWall Street Ratings and Target Price Views on Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Telanagana Press (NASDAQ:AERI)
telanaganapress.com - July 11 at 3:20 PM
news.cmlviz.com logoAerie Pharmaceuticals Inc Realized Volatility Hits Elevated Level - CML News (NASDAQ:AERI)
news.cmlviz.com - July 11 at 3:20 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Aerie Pharmaceuticals, Inc. (AERI) - Fiscal Standard (NASDAQ:AERI)
www.fiscalstandard.com - July 11 at 8:07 AM
investornewswire.com logoIs $50 Within Reach For Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)? - Investor Newswire (NASDAQ:AERI)
www.investornewswire.com - July 8 at 8:31 PM
News IconCan Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 6 at 3:20 PM
twst.com logoAerie Pharmaceuticals Inc.: Aerie Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference - The Wall Street Transcript (NASDAQ:AERI)
www.twst.com - July 6 at 3:20 PM
News IconStock Tracking Down This Month; Investor Alert on Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) - Engelwood Daily (NASDAQ:AERI)
www.engelwooddaily.com - July 6 at 8:06 AM
publicnow.com logoAerie Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:AERI)
www.publicnow.com - July 6 at 7:41 AM

Social

Aerie Pharmaceuticals (NASDAQ:AERI) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff